By discriminatory PCR assays, we detected a mean 6-fold increase of HERV-W/MSRVenv DNA copy number in MS patients with respect to healthy controls, but unchanged numbers of HERV-W/Syncytin-1 DNA copies [25]. This evidence concerns the gene ERVW-1 and myeloid sarcoma.